Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-1260
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-10-03T06:55:44.813333Z
status: published
lens: g_space
sector: health
headline: Longitudinal symptom severity tracking in vagus nerve stimulation patients: a 2-stage LLM-based pipeline with explainable AI
dek: Objectives To produce the first structured longitudinal dataset of symptom severity trajectories in vagus nerve stimulation (VNS) patients using a 2-stage large language model pipeline for automated symptom severity extraction from clinical notes, as part of the NIH-funded research evaluating vagal excitations and anatomical linkages (U54AT012307). Materials and methods We analyzed 1427 annotated clinical notes from 95 patients across 5 corpora. LLaMA models (3.2-1B, 3.2-3B, and 3.3-70B) were fine-tuned to class…
gain_title: Fine-tuned LLaMA models extracted symptom presence and severity from free-text notes with high F1 scores, enabling the first structured quarterly trajectories for VNS patients.
problem_title: (none)
trace_subject: (none)
gain_reading: Fine-tuned LLaMA models extracted symptom presence and severity from free-text notes with high F1 scores, enabling the first structured quarterly trajectories for VNS patients.
gain_evidence: Severity F1-scores ranged from 0.76 to 0.96, and symptom classification reached 0.99 for high-prevalence symptoms
problem_reading: (none)
problem_evidence: (none)
quick_read: Researchers built a two-stage large language model pipeline to turn free-text clinical notes into structured symptom severity data for vagus nerve stimulation patients, part of NIH-funded work U54AT012307. Using 1427 annotated notes from 95 patients, LLaMA models classified symptoms and then graded severity, producing quarterly trajectories for 23 VNS patients compared to a 10-patient NSQIP surgical control.

The work matters because it moves VNS monitoring from population averages to individualized trajectories that could inform treatment-response prediction and device programming, but uncertainty remains about cross-domain reliability for low-prevalence psychiatric symptoms and about causal attribution given the small, unmatched control cohort and exploratory equity analyses.
limitation: 
tag: Evidence-backed gain
key_points: Analyzed 1427 annotated clinical notes from 95 patients across 5 corpora using LLaMA 3.2-1B, 3.2-3B, and 3.3-70B models. | Stage 1 classified 13 symptoms as present, absent, or negated; stage 2 graded severity as indeterminate, mild, moderate, or severe. | Validation corpus (VNS vs NSQIP) explained 29.4% of variance with no significant source-corpus effect, cited as support for cross-domain generalizability. | Longitudinal tracking in 23 VNS patients versus 10-patient surgical control cohort showed median 0.5 quarters to meaningful seizure improvement.
rundown: The team fine-tuned three LLaMA models to first detect 13 symptoms and then assign severity levels, evaluating performance across five corpora including VNS and NSQIP notes. They report that validation corpus was the dominant variance factor at 29.4% with no significant source-corpus effect.

From quarterly trajectories in 23 VNS patients, the authors observed 50% responders, 25% non-responders, and 25% worsened, with median 0.5 quarters to improvement, while noting the absence of post-surgical decline in the unmatched 10-patient NSQIP cohort does not confirm VNS specificity.
sources:
- peer_reviewed | JAMIA Open | https://doi.org/10.1093/jamiaopen/ooag195 | 2026-10-01
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

fda06cf647b991e6048dc8873fc4e687de787c9266b93446116922fc03dcf9cd

previous

0000000000000000000000000000000000000000000000000000000000000000